Elizabeth is an award-winning marketing professional with a demonstrated history of working in the biotechnology industry. She has supported patient, HCP, and support services areas of the business and has focused on rare/orphan disease brands for over 5 years. In 2022, she was awarded the PM360 2022 Trailblazer “Brand Champion” Award in the Diabetes/Metabolic Disorders Category, a national award that celebrates innovative marketing work within the pharmaceutical industry. Prior to working in marketing, she supported healthcare brands in the communications and advertising industries. Elizabeth graduated from Wellesley College with departmental honors in English, and is pursuing her MBA at Boston University’s Questrom School of Business. After college, she attended Columbia University’s Graduate School of Journalism, where she received a certificate in publishing.